ACACB
Summary: Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis. There is evidence for the presence of two ACC-beta isoforms. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
acetyl-CoA carboxylase beta | MIM:601557 | Ensembl:ENSG00000076555 | HGNC:HGNC:85 | PA24422 | 12q24.11 |
GO terms in ACACB
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IDA | GO:0003989 | acetyl-CoA carboxylase activity |
MF | TAS | GO:0003989 | acetyl-CoA carboxylase activity |
MF | IEA | GO:0004075 | biotin carboxylase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IEA | GO:0009374 | biotin binding |
MF | IPI | GO:0042802 | identical protein binding |
MF | IEA | GO:0046872 | metal ion binding |
BP | IDA | GO:0006084 | acetyl-CoA metabolic process |
BP | IEA | GO:0006633 | fatty acid biosynthetic process |
BP | TAS | GO:0006853 | carnitine shuttle |
BP | IEA | GO:0010629 | negative regulation of gene expression |
BP | IEA | GO:0010884 | positive regulation of lipid storage |
BP | IEA | GO:0010906 | regulation of glucose metabolic process |
BP | IEA | GO:0014070 | response to organic cyclic compound |
BP | TAS | GO:0031325 | positive regulation of cellular metabolic process |
BP | IEA | GO:0031667 | response to nutrient levels |
BP | IEA | GO:0031999 | negative regulation of fatty acid beta-oxidation |
BP | IEA | GO:0042493 | response to drug |
BP | IEA | GO:0043086 | negative regulation of catalytic activity |
BP | TAS | GO:0045540 | regulation of cholesterol biosynthetic process |
BP | IDA | GO:0051289 | protein homotetramerization |
BP | IEA | GO:0060421 | positive regulation of heart growth |
BP | IEA | GO:0097009 | energy homeostasis |
BP | IEA | GO:2001295 | malonyl-CoA biosynthetic process |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005739 | mitochondrion |
CC | TAS | GO:0005741 | mitochondrial outer membrane |
CC | TAS | GO:0005829 | cytosol |
CC | IEA | GO:0012505 | endomembrane system |
Gene expression in normal tissue: ACACB
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ACACB
Database | Pathway ID | Pathway Des. |
---|---|---|
pharmgkb | PA165948566 | Metformin Pathway, Pharmacodynamic |
humancyc | PWY-5966-1 | fatty acid biosynthesis initiation |
humancyc | PWY0-1264 | biotin-carboxyl carrier protein assembly |
netpath | Pathway_Leptin | Leptin |
kegg | hsa00061 | Fatty acid biosynthesis - Homo sapiens (human) |
kegg | hsa00620 | Pyruvate metabolism - Homo sapiens (human) |
kegg | hsa00640 | Propanoate metabolism - Homo sapiens (human) |
kegg | hsa04152 | AMPK signaling pathway - Homo sapiens (human) |
kegg | hsa04910 | Insulin signaling pathway - Homo sapiens (human) |
kegg | hsa04920 | Adipocytokine signaling pathway - Homo sapiens (human) |
kegg | hsa04922 | Glucagon signaling pathway - Homo sapiens (human) |
kegg | hsa04931 | Insulin resistance - Homo sapiens (human) |
wikipathways | WP1403 | AMP-activated Protein Kinase (AMPK) Signaling |
wikipathways | WP2034 | Leptin signaling pathway |
wikipathways | WP2380 | Brain-Derived Neurotrophic Factor (BDNF) signaling pathway |
wikipathways | WP2593 | JAK-STAT |
wikipathways | WP2706 | Activation of gene expression by SREBF (SREBP) |
wikipathways | WP357 | Fatty Acid Biosynthesis |
wikipathways | WP3888 | VEGFA-VEGFR2 Signaling Pathway |
wikipathways | WP4010 | Liver steatosis AOP |
wikipathways | WP4018 | Pathways in clear cell renal cell carcinoma |
wikipathways | WP4206 | Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway |
reactome | R-HSA-1430728 | Metabolism |
reactome | R-HSA-163685 | Integration of energy metabolism |
reactome | R-HSA-163765 | ChREBP activates metabolic gene expression |
reactome | R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) |
reactome | R-HSA-196780 | Biotin transport and metabolism |
reactome | R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors |
reactome | R-HSA-196854 | Metabolism of vitamins and cofactors |
reactome | R-HSA-200425 | Import of palmitoyl-CoA into the mitochondrial matrix |
reactome | R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) |
reactome | R-HSA-556833 | Metabolism of lipids |
reactome | R-HSA-8957322 | Metabolism of steroids |
reactome | R-HSA-8978868 | Fatty acid metabolism |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD188 | Piperlongumine | 3 |
iGMDRD399 | Selumetinib | 2 |
iGMDRD74 | Idarubicin | 1 |
iGMDRD577 | BIX01294 | 4 |
iGMDRD562 | Navitoclax | 4 |
iGMDRD60 | Quinoclamine | 2 |
iGMDRD640 | CAY10618 | 3 |
iGMDRD64 | Parbendazole | 4 |
iGMDRD451 | Serdemetan | 2 |
iGMDRD138 | PX 12 | 1 |
iGMDRD255 | SB225002 | 2 |
iGMDRD171 | Pemetrexed | 1 |
iGMDRD782 | DC-45-A2 | 4 |
iGMDRD441 | TW 37 | 2 |
iGMDRD885 | Compound 110 | 2 |
iGMDRD187 | BRD9876 | 1 |
iGMDRD446 | LY 2183240 | 5 |
iGMDRD71 | Sparfosic acid | 2 |
iGMDRD639 | YK 4-279 | 1 |
iGMDRD193 | Fqi1 | 3 |
iGMDRD61 | Kinetin riboside | 4 |
iGMDRD280 | CYTOCHALASIN B | 4 |
iGMDRD394 | BX-795 | 4 |
iGMDRD466 | Chaetocin | 3 |
iGMDRD634 | SCHEMBL2608041 | 2 |
iGMDRD554 | CHEMBL1434137 | 2 |
iGMDRD599 | Salermide | 2 |
iGMDRD387 | CHIR-99021 | 1 |
iGMDRD229 | B02 | 3 |
iGMDRD427 | ABT737 | 1 |
iGMDRD781 | Sirolimus | 2 |
iGMDRD82 | Quiflapon | 2 |
iGMDRD322 | FK 866 | 3 |
iGMDRD121 | GMX1778 | 6 |
iGMDRD158 | NSC141540 | 3 |
iGMDRD6 | AM-580 | 3 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD231 | Importazole | 3 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD901 | ELCPK | 1 |
iGMDRD177 | Teniposide | 2 |
iGMDRD84 | Lovastatin acid | 4 |
iGMDRD486 | Tosedostat | 1 |
iGMDRD512 | nutlin 3 | 1 |
iGMDRD532 | Olaparib | 2 |
iGMDRD560 | MK-2206 | 3 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
iGMDRD299 | ICL 670 | 1 |
iGMDRD79 | Gemcitabine | 7 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ACACB